APC.H — Advanced Proteome Therapeutics Income Statement

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual income statement for Advanced Proteome Therapeutics, fiscal year end - July 31st, USD millions except per share, conversion factor applied.

	2018 July 31st	2019 July 31st	2020 July 31st	2021 July 31st	2022 July 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Total Revenue	0	0	0	0	0
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1.17	0.936	0.57	0.657	0.96
Operating Profit	-1.17	-0.936	-0.57	-0.657	-0.96
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.893	-0.461	-0.541	-1.92	0.597
Net Income After Taxes	-0.893	-0.461	-0.541	-1.92	0.597
Minority Interest
Net Income Before Extraordinary Items
Net Income	-0.745	-0.333	-0.451	-1.83	0.76
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-0.745	-0.333	-0.451	-1.83	0.76
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.05	-0.019	-0.02	-0.06	0.019